ACCORDI, BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 3.749
AS - Asia 1.203
EU - Europa 894
AF - Africa 295
SA - Sud America 246
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 8
Totale 6.430
Nazione #
US - Stati Uniti d'America 3.577
SG - Singapore 445
CN - Cina 294
DE - Germania 182
BR - Brasile 156
HK - Hong Kong 117
IT - Italia 103
FI - Finlandia 83
PL - Polonia 63
GB - Regno Unito 55
RU - Federazione Russa 54
SE - Svezia 48
CA - Canada 35
VN - Vietnam 34
FR - Francia 33
IN - India 31
UA - Ucraina 28
NL - Olanda 25
TR - Turchia 22
MX - Messico 21
AT - Austria 19
AR - Argentina 17
EC - Ecuador 16
ZA - Sudafrica 16
UZ - Uzbekistan 15
AO - Angola 14
TJ - Tagikistan 14
BJ - Benin 13
CI - Costa d'Avorio 13
IE - Irlanda 13
RE - Reunion 13
CV - Capo Verde 12
JM - Giamaica 12
JO - Giordania 12
KR - Corea 12
MA - Marocco 12
DK - Danimarca 11
ES - Italia 11
GH - Ghana 11
HN - Honduras 11
JP - Giappone 11
KG - Kirghizistan 11
MK - Macedonia 11
RS - Serbia 11
AM - Armenia 10
AZ - Azerbaigian 10
BG - Bulgaria 10
BZ - Belize 10
CH - Svizzera 10
CO - Colombia 10
PK - Pakistan 10
VE - Venezuela 10
AU - Australia 9
CY - Cipro 9
GM - Gambi 9
IS - Islanda 9
NA - Namibia 9
AL - Albania 8
BA - Bosnia-Erzegovina 8
BB - Barbados 8
CM - Camerun 8
CU - Cuba 8
DZ - Algeria 8
EG - Egitto 8
GR - Grecia 8
HT - Haiti 8
ID - Indonesia 8
IQ - Iraq 8
KE - Kenya 8
KH - Cambogia 8
KZ - Kazakistan 8
LB - Libano 8
LU - Lussemburgo 8
LY - Libia 8
ML - Mali 8
PS - Palestinian Territory 8
SI - Slovenia 8
TN - Tunisia 8
UY - Uruguay 8
YE - Yemen 8
AF - Afghanistan, Repubblica islamica di 7
BO - Bolivia 7
BW - Botswana 7
BY - Bielorussia 7
CL - Cile 7
CZ - Repubblica Ceca 7
ET - Etiopia 7
GN - Guinea 7
IL - Israele 7
IR - Iran 7
LA - Repubblica Popolare Democratica del Laos 7
MR - Mauritania 7
MY - Malesia 7
NZ - Nuova Zelanda 7
PY - Paraguay 7
SY - Repubblica araba siriana 7
TT - Trinidad e Tobago 7
UG - Uganda 7
AE - Emirati Arabi Uniti 6
BF - Burkina Faso 6
Totale 6.164
Città #
Fairfield 537
Ashburn 353
Woodbridge 352
Chandler 326
Singapore 290
Ann Arbor 251
Cambridge 233
Houston 189
Seattle 182
Wilmington 164
Hong Kong 115
Beijing 88
Santa Clara 65
Boardman 62
Jacksonville 58
San Diego 57
Princeton 45
Bytom 43
Helsinki 41
Medford 36
Munich 35
Los Angeles 34
Padova 32
Des Moines 28
New York 27
Chicago 23
Nanjing 22
Turku 16
Redondo Beach 14
Shenyang 14
Tashkent 14
Abidjan 13
Cotonou 13
Luanda 13
Vienna 13
Dong Ket 12
Dublin 12
Dushanbe 12
North York 12
Amman 11
London 11
Nuremberg 11
Baku 10
Bishkek 10
Jinan 10
Shanghai 10
São Paulo 10
Warsaw 10
Buffalo 9
Guangzhou 9
Hefei 9
Praia 9
Rio de Janeiro 9
Sofia 9
Yerevan 9
Atlanta 8
Brooklyn 8
Jiaxing 8
Kingston 8
Montevideo 8
Ottawa 8
Phnom Penh 8
Accra 7
Bamako 7
Chennai 7
Conakry 7
Dearborn 7
Denver 7
Elk Grove Village 7
Havana 7
Kampala 7
Nairobi 7
Nicosia 7
Poplar 7
Zhengzhou 7
Amsterdam 6
Ankara 6
Apia 6
Bridgetown 6
Castries 6
Falls Church 6
Guayaquil 6
Hebei 6
Istanbul 6
Johannesburg 6
Kingstown 6
Managua 6
Montreal 6
Nouakchott 6
Noumea 6
Quito 6
Reykjavik 6
Saint-Denis 6
San Pedro Sula 6
Tokyo 6
Ulan Bator 6
Vientiane 6
Addis Ababa 5
Antananarivo 5
Banjul 5
Totale 4.296
Nome #
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia 245
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins 218
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints 217
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML. 217
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 206
Hovering between death and life: Natural apoptosis and phagocytes in the blastogenetic cycle of the colonial ascidian Botryllus schlosseri 204
Glucocorticoid resistance is reverted by LCK inhibition in pediatric T-cell acute lymphoblastic leukemia 203
Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALL 197
Choline kinase alpha inhibition by EB-3D triggers cellular senescence, reduces tumor growth and metastatic dissemination in breast cancer 192
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 190
Ribociclib, a Cdk4/Cdk6 kinase inhibitor, enhances glucocorticoid sensitivity in B-acute lymphoblastic leukemia (B-All) 190
EB-3D a novel choline kinase inhibitor induces deregulation of the AMPK-mTOR pathway and apoptosis in leukemia T-cells 186
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells 182
Annexin 2A sustains glioblastoma cell dissemination and proliferation 181
Pre-clinical evaluation of second generation pim inhibitors for the treatment of t-cell acute lymphoblastic leukemia and lymphoma 180
Inhibition of PI3K Signalling Selectively Affects Medulloblastoma Cancer Stem Cells 176
SYK targeting represents a potential therapeutic option for relapsed resistant pediatric ETV6-RUNX1 B-acute lymphoblastic leukemia patients 176
Targeting BAG-1: A novel strategy to increase drug efficacy in acute myeloid leukemia 173
Interleukin-22 in the diagnosis of active chronic graft-versus-host disease in paediatric patients 169
Phosphoproteomic analysis reveals hyperactivation of mTOR/STAT3 and LCK/Calcineurin axes in pediatric early T-cell precursor ALL 168
Expression and role of hERG1 channels in pediatric acute lymphoblastic Leukemias: Shortcoming of drug resistance by hERG1 channel inhibitors in stoma-supported leukaemia cell cultures in vitro. 163
miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma 163
AMPK INHIBITION INDUCES APOPTOSIS IN PEDIATRIC B-ALL CELLS WITH MLL GENE REARRANGEMENTS 154
Reverse Phase Protein Array (RPPA) of High Risk ALL 149
Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction 140
JNK1 and ERK1/2 modulate lymphocyte homeostasis via BIM and DRP1 upon AICD induction 140
Ruxolitinib as a novel therapeutic option for poor prognosis t-lbl pediatric patients 139
USP7 cooperates with NOTch1 to drive the oncogenic transcriptional program in T-cell leukemia 137
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in Leukemia 135
The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. 131
BAG1 Overexpression Restrains the Anti-Apoptotic BCL2, MCL1 and HSP70 Proteins in Acute Myeloid Leukemia 128
A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction. 128
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups. 124
Phosphoproteomic profiling of pediatric B-ALL identifies in mill patients a new signaling pathway for targeted therapy 112
Validation by RQ-PCR and flow cytometry of alpha-defensin 1-3 (DEFA 1-3) overexpression in relapsed and refractory acute lymphoblastic leucemia. 111
NUP214-ABL1 fusion in childhood T-ALL 110
Overcoming Chemotherapy Resistance in Childhood Acute Lymphoblastic Leukemia by Targeting Ion Channels. 108
Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups 95
Synergistic cytotoxicity of dual PI3K/mTOR and FLT3 inhibition in FLT3-ITD AML cells 92
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis 88
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit 86
Totale 6.503
Categoria #
all - tutte 21.881
article - articoli 21.881
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021431 0 0 0 0 41 18 38 53 68 78 69 66
2021/2022657 30 58 73 34 30 36 113 46 28 15 75 119
2022/2023573 94 79 17 87 70 70 0 39 68 7 34 8
2023/2024266 11 50 30 22 22 30 16 10 7 16 25 27
2024/20251.051 1 75 45 47 133 25 54 102 87 37 171 274
2025/20261.745 234 309 480 682 40 0 0 0 0 0 0 0
Totale 6.503